Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 1;13(23):6057. doi: 10.3390/cancers13236057

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Survival curves for the correlation between the molecular findings and clinical features related to crizotinib treatment. (A) Kaplan–Meier estimates for different levels of immunoreactivity divided by low (negative and weakly positive) and high (moderately and strongly positive) expressions. Overall survival is compared between high and low expressions of phosphorylated MAPK. (B) Overall survival and progression-free survival for cases with different copy number alteration statuses of chromosomes 9q and 12q24.33. (C) Progression-free survival for cases with and without alterations in chromatin organization.